Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FYPZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,594
Award facts
- Contract value 100% obligated
- $2,594.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,594.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with an ultimate completion date of September 5, 2025. Zepbound is a semaglutide-based medication indicated for weight management and diabetes treatment. This non-set-aside award was competitively procured and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle, the DLA Troop Support Medical prime vendor contract (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA Troop Support Medical contract represents a comprehensive global pharmaceutical support vehicle enabling the supply of a wide range of medications and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. This delivery order for Zepbound reflects AmerisourceBergen's ongoing role in supplying specialized pharmaceutical products across multiple therapeutic domains to support federal healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FYPZL?
SPE2DB25FYPZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FYPZL worth?
The government has obligated $2,594 on SPE2DB25FYPZL.
Is contract SPE2DB25FYPZL an order under another contract?
Yes. SPE2DB25FYPZL is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYPZL competed?
The extent of competition for SPE2DB25FYPZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award